Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Papillary Epinephrine Spraying for Post-ERCP Pancreatitis
NCT03057769Terminated
- Sponsor
- Air Force Medical University
- Start
- Feb 2017
- Primary completion
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of epinephrine in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) (2 arms), sponsored by Air Force Medical University. Primary endpoint: Overall post-ERCP pancreatitis at 30 days. Started Feb 2017; status: terminated.
02
Drugs
epinephrine
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT03057769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03057769.